We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Vernalis | LSE:VER | London | Ordinary Share | GB00B3Y5L754 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 6.17 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
12/6/2015 09:43 | Hi, you can see the headline broker recommendations history on a rival share price/info website that I won't mention but begins with M!Plus the updated recommendation yesterday was reported on a number of sites eg http://www.wkrb13.co | photon | |
12/6/2015 08:33 | Thanks photon,can you post their article? | fhmktg | |
12/6/2015 05:51 | Stifel upped their price target from 74p to 103p yesterday. They had previously been cautiously positive and upped targets in relatively small increments. | photon | |
11/6/2015 12:37 | I'm somewhat surprised at the slow development of the cough formulations. We are talking about relatively simple formulation of actives ( all well known) into delivery systems. At the rate we are going it could take 5-7 years to get these into approval. With NDA submission in spring/summer 2016 its going to be the cold and cough season of 2017 before #2 hits the market. Am I missing something? | fhmktg | |
05/6/2015 15:52 | Two degrees, if you are talking about the director buy, that was over a month ago, hence lower price. | battyliveson | |
05/6/2015 15:46 | how does he managed to get them at an average of 59.9p when they were around 69p yesterday | twodegrees | |
05/6/2015 14:35 | Still ticking up nicely. Got some for the Sipp as a long term hold as will be news driven. Has great potential and attractive to big pharma if US cold relief launches well. Batty | battyliveson | |
02/6/2015 16:06 | climbing again. | twodegrees | |
18/5/2015 17:46 | Lots of buying at the close! | fhmktg | |
14/5/2015 16:07 | Thanks for that twodegrees. I'll keep on topping up here I think. | investordave | |
14/5/2015 16:06 | 3. Full name of person(s) Woodford Investment subject to the notification Management LLP (Woodford) obligation: -------------------- 4. Full name of shareholder(s) Clients of Woodford (if different from 3.): -------------------- 5. Date of the transaction 29 April 2015 and date on which the threshold is crossed or reached: -------------------- 6. Date on which issuer 30 April 2015 notified: -------------------- 7. Threshold(s) that is/are crossed or reached: 18%, 19% -------------------- 8. Notified details: -------------------- A: Voting rights attached to shares -------------------- Class/type Situation Resulting situation after of previous the triggering transaction shares to the triggering transaction if possible using the ISIN CODE --------------- -------------------- Number Number Number Number of % of voting of of of voting rights Shares Voting shares rights Rights --------------- ----------- ----------- ----------- -------------------- Direct Indirect Direct Indirect --------------- ----------- ----------- ----------- ----------- --------- ------- --------- Ordinary 1p Shares GB00B3Y5L754 77,389,076 77,389,076 85,550,924 85,550,924 19.3% --------------- ----------- ----------- ----------- ----------- --------- ------- --------- | twodegrees | |
14/5/2015 15:54 | two degrees - Do you mean 20% of the company? If so, that's quite a statement of confidence. | investordave | |
14/5/2015 15:47 | investordave, woodford keeps buying I think he has about 20% now | twodegrees | |
14/5/2015 15:29 | Some sizeable trades going through, be interesting to see what they do when they get tipped ! Woodford been a holder for some time and keeps buying ! | toffeeman4 | |
14/5/2015 15:06 | twodegrees - I didn't know that Woodford had bought Vernalis. What's your source for that please? | investordave | |
14/5/2015 14:41 | I bought these in british biotech at £1.25 and never ever thought I might get anything back after they fell to the floor..but I suppose investments sometimes take time to materialise and this one is doing fine for me...small steps at a time and woodford on the case | twodegrees | |
14/5/2015 12:34 | hvs - I agree. Something bubbling here. | investordave | |
14/5/2015 12:28 | Just hang in there. Feels a bid is coming soon. Way undervalued. | hvs | |
13/5/2015 16:19 | this just keep rising and yet it appears not to get so much publicity, more for us then. | twodegrees | |
06/5/2015 17:00 | Always good when the directors put their money into shares! | fhmktg | |
01/5/2015 23:47 | Fhmktg I don't think British biotech original shareholders will get their stake money back for quite a while yet. Vernalis however is set to do very well. | barrie16 | |
01/5/2015 12:06 | Useful analysis by Motley Fool | fhmktg | |
01/5/2015 09:10 | Nice one today. This is going to EXPLODE. | hvs | |
01/5/2015 08:08 | That's a good message for Mr W over his morning coffee!Well done Vernalis! | fhmktg | |
01/5/2015 07:49 | Well done Vernalis There is probably little clinical need (or rationale) for these TRIS products, but it certainly fulfils a commercial need and should be a big boost for the company and for shareholders. They have approval in the US based on PK studies, the chances of getting approval in Europe on PK studies (without accompanying clinical trials in patients with coughs/colds) are close to zero | timbo003 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions